The Delhi High Court will on Monday pronounce its order on a plea by several doctors' associations against Yoga guru Ramdev over his claim of 'Coronil' being a "cure" for Covid-19.
The plea forms a part of a 2021 lawsuit by the doctors' associations against the Ramdev, his associate Acharya Balkrishna as well as Patanjali Ayurveda.
Justice Anup Jairam Bhambhani had reserved the order on the issue on May 21 after hearing the parties.
According to the lawsuit, Ramdev made "unsubstantiated claims" with respect to 'Coronil' being a cure for Covid-19, contrary to the licence granted to the drug for merely being an "immuno-booster".
The senior counsel appearing for the doctors had sought a direction to restrain the defendants, Ramdev and others, from making further similar statements.
Three Resident Doctors' Association of the All India Institute of Medical Sciences at Rishikesh, Patna and Bhubaneswar as well as Association of Resident Doctors, Post Graduate Institute of Medical Education & Research, Chandigarh; Union of Resident Doctors of Punjab (URDP); Resident Doctors' Association, Lala Lajpat Rai Memorial Medical College, Meerut; and the Telangana Junior Doctors' Association, Hyderabad had moved the high court in 2021 against Ramdev and others.
They alleged there was a misinformation campaign and a marketing strategy to further the sales of the product sold by Ramdev, including 'Coronil' which claimed to be an alternative treatment for Covid-19.
On October 27, 2021, the high court had issued summons to Ramdev and others on the lawsuit, saying that it was not frivolous and a case for its institution was "definitely" made out.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)